* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
MTPConnect – Project Fund Recipients Lead Company Australian Academy of Technological Sciences A consortium of 14 pharma companies and sector organisations STC Australia Murdoch Children’s Research Institute Monash University with CSIRO St Vincent’s Hospital (Melbourne) Ltd AusBiotech Ltd Monash University with CSIRO Clinical Oncology Society of Australia (COSA) Cancer Therapeutics CRC Pty Ltd Vaxine Pty Ltd Flinders University of South Australia Centre for Entrepreneurial Research and Innovation Queensland University of Technology Project Industry Mentoring Network in STEM programme Description Narrowing the cultural gap between business and academia through a mentoring programme, linking PhD students with qualified industry mentors. The Bridge Programme Transferring practical skills in pharmaceutical commercialisation through training, including direct exposure to industry practitioners. National MedTech Accelerator programme National Digital Health Initiative Creating infrastructure to accelerate commercialisation of high-value advanced manufacturing and medical devices. Upgrade the CSIRO protein production platform Australia’s first robotics and biomedical engineering centre Comprehensive global investment programme Australian hub for regenerative medicine Creating an integrated ecosystem for the development and commercialisation of evidence-based digital health products. Upgrading CSIRO’s production platform capability and developing a Master’s degree in manufacturing for the platform. Researchers, clinicians, engineers and industry partners will work alongside each other to build biological structures like organs, bone and brain tissue. Developing a comprehensive global investment programme for Australian life science sector companies and researchers. Supporting the development of foundational technologies to accelerate the commercialisation of regenerative medicines. Tele‐health strategy to increase access to clinical trials National framework for drug discovery organisations Landscaping Australian vaccine research capabilities and services National Medical Device Partnering Programme Translational research and training Implementing a strategy to increase patient’s access to cancer clinical trials closer to their homes, whilst ensuring the proper conduct of the trials. Providing access to state-of-the-art facilities and software for drug discovery work. Establish a biofabrication research centre This centre will bring together university researchers, industry innovators and clinical end-users to develop 3D digital and other advanced manufacturing technologies. This information will assist research in the medical technologies, biotechnology and pharmaceutical sector. This will bring together research, clinical and industry partners in a streamlined process for collaboration and product development. This will be a national consortium for translational medical technology and pharmaceuticals research and training.